Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
52,223,325
-
Total 13F shares
-
2,527,104
-
Share change
-
-1,141,318
-
Total reported value
-
$3,132,035
-
Price per share
-
$1.24
-
Number of holders
-
23
-
Value change
-
-$2,355,232
-
Number of buys
-
10
-
Number of sells
-
10
Institutional Holders of DiaMedica Therapeutics Inc. - Common Shares, no par value (DMAC) as of Q3 2022
As of 30 Sep 2022,
DiaMedica Therapeutics Inc. - Common Shares, no par value (DMAC) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,527,104 shares.
The largest 10 holders included
COOPERMAN LEON G, VANGUARD GROUP INC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BlackRock Inc., STATE STREET CORP, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and Bank of New York Mellon Corp.
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.